Therefore, we speculate that CX08005 treatment for NAFLD may be related to the inhibition of oxidative stress and the secretion of pro-inflammatory cytokines mediated by insulin sensitization and hepatic microcirculation recovery, and the specific mechanism needs to be further explored. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.